Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
Rivaroxaban is an effective and safe alternative to warfarin in patients with atrial fibrillation
and venous thromboembolism. We tested the efficacy and safety of rivaroxaban compared …
and venous thromboembolism. We tested the efficacy and safety of rivaroxaban compared …
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial …
D Brieger, J Amerena, JR Attia… - Medical Journal of …, 2018 - Wiley Online Library
Introduction: Atrial fibrillation (AF) is increasing in prevalence and is associated with
significant morbidity and mortality. The optimal diagnostic and treatment strategies for AF are …
significant morbidity and mortality. The optimal diagnostic and treatment strategies for AF are …
Medication non-adherence in chronic kidney disease: a mixed-methods review and synthesis using the theoretical domains framework and the behavioural change …
Objective Medication non-adherence is a well-recognised issue in chronic diseases but data
in patients with chronic kidney disease (CKD) not receiving kidney replacement therapy …
in patients with chronic kidney disease (CKD) not receiving kidney replacement therapy …
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial
Thrombotic antiphospholipid syndrome (TAPS) is characterized by venous, arterial, or
microvascular thrombosis. Patients with TAPS merit indefinite anticoagulation, and warfarin …
microvascular thrombosis. Patients with TAPS merit indefinite anticoagulation, and warfarin …
[HTML][HTML] Prevalence of and factors associated with health literacy among people with Noncommunicable diseases (NCDs) in South Asian countries: A systematic …
B Khatiwada, B Rajbhandari, SK Mistry… - … epidemiology and global …, 2022 - Elsevier
Problem considered Health literacy increases the ability of people living with non-
communicable diseases (PLWNCDs) to read and understand medical information, access …
communicable diseases (PLWNCDs) to read and understand medical information, access …
The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation
CA Rolls, KO Obamiro, L Chalmers… - Cardiovascular …, 2017 - Wiley Online Library
Background Patients' knowledge regarding their oral anticoagulant (OAC) treatment for
stroke prevention in atrial fibrillation (AF), their level of medication adherence, and health …
stroke prevention in atrial fibrillation (AF), their level of medication adherence, and health …
Risk factors for medication non-adherence among atrial fibrillation patients
SR Reading, MH Black, DE Singer, AS Go… - BMC cardiovascular …, 2019 - Springer
Background Atrial fibrillation (AF) patients are routinely prescribed medications to prevent
and treat complications, including those from common co-occurring comorbidities. However …
and treat complications, including those from common co-occurring comorbidities. However …
[HTML][HTML] Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: a surveillance study
Background In contrast to vitamin K antagonists (VKA), direct oral anticoagulants (DOAC's)
are not strictly monitored and dose titrated by anticoagulation clinics in the Netherlands. This …
are not strictly monitored and dose titrated by anticoagulation clinics in the Netherlands. This …
Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation
L Desteghe, J Vijgen, P Koopman… - European heart …, 2018 - academic.oup.com
Aims To evaluate the effect of telemonitoring on adherence to non-vitamin K antagonist oral
anticoagulants (NOACs) in atrial fibrillation (AF) patients. Methods and results A …
anticoagulants (NOACs) in atrial fibrillation (AF) patients. Methods and results A …
Factors associated with primary nonadherence to newly initiated direct oral anticoagulants in patients with nonvalvular atrial fibrillation
A Charlton, X Vidal, M Sabaté, E Bailarín… - Journal of managed …, 2021 - jmcp.org
BACKGROUND: Direct oral anticoagulants (DOACs) are widely used for the prevention of
stroke in nonvalvular atrial fibrillation (NVAF); however, real-world primary nonadherence …
stroke in nonvalvular atrial fibrillation (NVAF); however, real-world primary nonadherence …